Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neurodana is a medical food or dietary supplement capsule marketed by Blue Heron Pharmaceuticals for the clinical dietary management of nutritional deficiencies, particularly those associated with peripheral neuropathy. The product contains a combination of active B-vitamin metabolites: L-methylfolate calcium (3 mg), pyridoxal 5-phosphate (35 mg), and methylcobalamin (2 mg). These components are essential for maintaining healthy nerve function, supporting the synthesis of neurotransmitters, and regulating homocysteine levels, which can be elevated in patients with diabetic neuropathy or other neurodegenerative conditions. By providing these vitamins in their bioactive forms, Neurodana bypasses the need for enzymatic conversion, which may be impaired in certain patient populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neurodana.